|
216
|
695
|
4oauC |
Complete human rnase l in complex with biological activators. |
|
224
|
694
|
4oavB |
Complete human rnase l in complex with 2-5a (5'-ppp heptamer), amppcp and rna substrate. |
|
166
|
627
|
3uztA |
Structure of the c13.18 rna aptamer in complex with g protein-coupled receptor kinase 2 |
|
102
|
356
|
4ux9A |
Crystal structure of jnk1 bound to a mkk7 docking motif |
|
83
|
306
|
5j9lA |
Crystal structure of cpt1691 bound to tak1-tab1 |
|
114
|
338
|
5j1wA |
Crystal structure of human clk1 in complex with pyrido[3,4-g]quinazoline derivative zw31 (compound 14) |
|
113
|
338
|
5j1vA |
Crystal structure of human clk1 in complex with pyrido[3,4-g]quinazoline derivative zw29 (compound 13) |
|
79
|
276
|
3uqfA |
C-src kinase domain in complex with bki rm-1-89 |
|
82
|
298
|
3unkA |
Cdk2 in complex with inhibitor yl5-083 |
|
81
|
276
|
3tucA |
Crystal structure of syk kinase domain with 1-benzyl-n-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
|
76
|
263
|
3uojA |
Aurora a in complex with rpm1715 |
|
87
|
301
|
3u6hA |
Crystal structure of c-met in complex with pyrazolone inhibitor 26 |
|
158
|
464
|
3upzA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with bumpless bki analog uw1243 |
|
103
|
310
|
3u6jA |
Crystal structure of the vegfr2 kinase domain in complex with a pyrazolone inhibitor |
|
84
|
272
|
3tubA |
Crystal structure of syk kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1r,2s)-2-phenylcyclopropyl)urea |
|
82
|
267
|
3uo5A |
Aurora a in complex with yl1-038-31 |
|
84
|
274
|
3tudA |
Crystal structure of syk kinase domain with n-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide |
|
65
|
246
|
3uqcA |
Structure of the intracellular kinase homology domain of rv3910 at 2.2 a resolution |
|
86
|
301
|
3u6iA |
Crystal structure of c-met in complex with pyrazolone inhibitor 58a |
|
80
|
298
|
3s00A |
Cdk2 in complex with inhibitor l4-14 |
|
85
|
277
|
3svvA |
Crystal structure of t338c c-src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9 |
|
75
|
298
|
3s0oA |
Cdk2 in complex with inhibitor rc-1-138 |
|
85
|
298
|
3sw7A |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
|
78
|
298
|
3s1hA |
Cdk2 in complex with inhibitor rc-2-39 |
|
107
|
357
|
3sa0A |
Complex of erk2 with norathyriol |
|
113
|
332
|
5m4uA |
Orthorhombic complex structure of human protein kinase ck2 catalytic subunit (isoform ck2alpha') with the inhibitor 4'-carboxy-6,8-chloro- flavonol (flc21) |
|
116
|
331
|
5m56A |
Monoclinic complex structure of human protein kinase ck2 catalytic subunit (isoform ck2alpha') with the inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) |
|
115
|
329
|
5m4cA |
Complex structure of human protein kinase ck2 catalytic subunit with a thieno[2,3-d]pyrimidin inhibitor crystallized under low-salt conditions |
|
80
|
277
|
5m57A |
Nek2 bound to arylaminopurine 6 |
|
96
|
290
|
5lwmA |
Crystal structure of jak3 in complex with compound 4 (fm381) |
|
90
|
272
|
5m53A |
Nek2 bound to arylaminopurine inhibitor 11 |
|
95
|
290
|
5lwnA |
Crystal structure of jak3 in complex with compound 5 (fm409) |
|
84
|
267
|
5lxmA |
Crystal structure of aurora-a bound to a hydrocarbon-stapled proteomimetic of tpx2 |
|
83
|
284
|
5lvmA |
Human pdk1 kinase domain in complex with adenine bound to the atp-binding site |
|
101
|
329
|
5m44A |
Complex structure of human protein kinase ck2 catalytic subunit with a thieno[2,3-d]pyrimidin inhibitor crystallized under high-salt conditions |
|
85
|
285
|
5lvpA |
Human pdk1 kinase domain in complex with an hm-peptide bound to the pif-pocket |
|
89
|
271
|
5lmbA |
Human spleen tyrosine kinase kinase domain in complex with azanaphthyridine inhibitor |
|
85
|
264
|
5l8lA |
Aurora-a kinase domain in complex with vnar-d01 (crystal form 1) |
|
82
|
292
|
5lqfA |
Cdk1/cyclinb1/cks2 in complex with nu6102 |
|
83
|
274
|
5l6pA |
Ephb3 kinase domain covalently bound to an irreversible inhibitor (compound 6) |
|
88
|
276
|
5m51A |
Nek2 bound to arylaminopurine compound 8 |
|
88
|
284
|
5lvnA |
Human pdk1 kinase domain in complex with adenosine bound to the atp-binding site |
|
77
|
297
|
5lmkC |
Structure of phopsho-cdk2-cyclin a in complex with an atp-competitive inhibitor |
|
86
|
274
|
5l6oA |
Ephb3 kinase domain covalently bound to an irreversible inhibitor (compound 3) |
|
57
|
284
|
5lohA |
Kinase domain of human greatwall |
|
112
|
347
|
5lcjA |
In-gel activity-based protein profiling of a clickable covalent erk 1/2 inhibitor |
|
112
|
331
|
5m4iA |
Complex structure of human protein kinase ck2 catalytic subunit with the inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) crystallized under high-salt conditions |
|
86
|
299
|
5lmkA |
Structure of phopsho-cdk2-cyclin a in complex with an atp-competitive inhibitor |
|
89
|
267
|
5l8kA |
Aurora-a kinase domain in complex with vnar-d01 (crystal form 2) |
|
117
|
330
|
5m4fA |
Complex structure of human protein kinase ck2 catalytic subunit with the inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) crystallized under low-salt conditions |
